Pain
Conference Coverage
Nerve growth factor antibody cuts OA pain with low AEs
CHICAGO – First phase 3 results from an OA trial testing a nerve growth factor antibody, tanezumab.
From the Journals
Careful follow-up is key in lupus psychosis
Treatment can lead to good outcomes for most patients with careful follow-up, according to a large international study.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
Opinion
FDA approval of powerful opioid tinged with irony
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
News
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
Feature
Palliative care update highlights role of nonspecialists
The latest guideline revision aims to establish a foundation for “gold-standard” palliative care.
Conference Coverage
TENS cuts fibromyalgia pain in large RCT
CHICAGO – Women with fibromyalgia who self-administered transcutaneous electrical nerve stimulation reported greater pain reduction than controls...
From the Journals
Short-term NSAIDs appear safe for high-risk patients
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients...
Feature
Suicide prevention in rheumatology: Engagement is key
From the Journals
Amitriptyline may be an alternative treatment for chronic low back pain
Conference Coverage
Opioid use in OA may mean more activity-limiting pain
LAS VEGAS – Persistent opioid use proved to be functionally limiting by the end of follow-up regardless of functional limitations at baseline.